doi: 10.3892/etm.2024.12560.
eCollection 2024 Jul.
[Retracted] Long non‑coding RNA receptor activator of nuclear factor‑κB ligand promotes cisplatin resistance in non‑small cell lung cancer cells
- PMID: 38765655
- PMCID: PMC11097129
- DOI: 10.3892/etm.2024.12560
Item in Clipboard
[Retracted] Long non‑coding RNA receptor activator of nuclear factor‑κB ligand promotes cisplatin resistance in non‑small cell lung cancer cells
Exp Ther Med.
.
Abstract
[This retracts the article DOI: 10.3892/etm.2021.9949.].
Copyright: © 2024 Zhu et al.
Retraction of
-
Long non-coding RNA receptor activator of nuclear factor-κ B ligand promotes cisplatin resistance in non-small cell lung cancer cells.Exp Ther Med. 2021 May;21(5):518. doi: 10.3892/etm.2021.9949. Epub 2021 Mar 22. Exp Ther Med. 2021. Retraction in: Exp Ther Med. 2024 May 01;28(1):272. doi: 10.3892/etm.2024.12560. PMID: 33815591 Free PMC article. Retracted.
Similar articles
-
[Retracted] Toll‑like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis.Exp Ther Med. 2024 Nov 4;29(1):10. doi: 10.3892/etm.2024.12760. eCollection 2025 Jan. Exp Ther Med. 2024. PMID: 39563883 Free PMC article.
-
[Retracted] Long non‑coding RNA SLC25A25‑AS1 exhibits oncogenic roles in non‑small cell lung cancer by regulating the microRNA‑195‑5p/ITGA2 axis.Oncol Lett. 2024 Aug 5;28(4):475. doi: 10.3892/ol.2024.14608. eCollection 2024 Oct. Oncol Lett. 2024. PMID: 39161331 Free PMC article.
-
[Retracted] MicroRNA‑877 inhibits cell proliferation and invasion in non‑small cell lung cancer by directly targeting IGF‑1R.Exp Ther Med. 2022 Sep 5;24(5):651. doi: 10.3892/etm.2022.11588. eCollection 2022 Nov. Exp Ther Med. 2022. PMID: 36168414 Free PMC article.
-
[Retracted] MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L.Exp Ther Med. 2022 Aug 9;24(4):620. doi: 10.3892/etm.2022.11557. eCollection 2022 Oct. Exp Ther Med. 2022. PMID: 36160892 Free PMC article.
-
[Retracted] 3,4‑Dihydroxyphenylethanol alleviates early brain injury by modulating oxidative stress and Akt and nuclear factor‑κB pathways in a rat model of subarachnoid hemorrhage.Exp Ther Med. 2024 Sep 30;28(6):444. doi: 10.3892/etm.2024.12734. eCollection 2024 Dec. Exp Ther Med. 2024. PMID: 39386941 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources